Trials / Unknown
UnknownNCT05520801
Primary Hepatobiliary Cancer Cohort of Central China
The Treatment and Prognosis of Primary Hepatobiliary Cancer: A Cohort Study in Central China
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This registry is designed as a longitudinal cohort study of patients diagnosed with primary hepatobiliary cancer in Tongji Hospital, Wuhan. This study collects the clinical-pathological features of hepatic malignant tumors and the current status of patients who received comprehensive treatment based on surgical treatment since 1998.
Detailed description
This longitudinal observational cohort study was designed to make standardized settlements, statistical treatments, and comprehensive analysis of primary hepatobiliary cancers in middle China, which summarize and estimate the population, tumor staging, treatment mode, clinical-pathological characteristics, and the prognosis, to provide evidence for standardized treatment of hepatobiliary cancers.
Conditions
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2024-12-31
- Completion
- 2025-03-31
- First posted
- 2022-08-30
- Last updated
- 2023-12-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05520801. Inclusion in this directory is not an endorsement.